BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1038 related articles for article (PubMed ID: 8543592)

  • 1. Biodistribution in tumour-bearing mice of polycationic, amphoteric and polyanionic branched polypeptides with a poly(L-lysine) backbone labelled with 125I and 111In: tumour accumulation less than that of labelled serum proteins.
    Pimm MV; Hudecz F
    J Cancer Res Clin Oncol; 1996; 122(1):45-54. PubMed ID: 8543592
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of chain lengths and backbone chirality on the bone-targeting ability of poly(glutamic acid)s.
    Xia J; Wang W; Jin X; Zhao J; Chen J; Li N; Xiao S; Lin D; Song Z
    Biomater Sci; 2024 Jun; ():. PubMed ID: 38913349
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Influence of glycyrrhizin on the evolution and respiration of Ehrlich ascites tumour cells.
    Rossi T; Galatulas I; Bossa R; Tampieri A; Tartoni P; Baggio G; Ruberto AI; Castelli M
    In Vivo; 1995; 9(3):183-6. PubMed ID: 8562878
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression of nma, a novel gene, inversely correlates with the metastatic potential of human melanoma cell lines and xenografts.
    Degen WG; Weterman MA; van Groningen JJ; Cornelissen IM; Lemmers JP; Agterbos MA; Geurts van Kessel A; Swart GW; Bloemers HP
    Int J Cancer; 1996 Feb; 65(4):460-5. PubMed ID: 8621228
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of fixation on interphase cytogenetic analysis by direct fluorescence in situ hybridization on cell imprints.
    Kapranos N; Kontogeorgos G; Frangia K; Kokka E
    Biotech Histochem; 1997 May; 72(3):148-51. PubMed ID: 9187738
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Vaccine therapy for cancer.
    Linehan DC; Goedegebuure PS; Eberlein TJ
    Ann Surg Oncol; 1996 Mar; 3(2):219-28. PubMed ID: 8646525
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Melatonin inhibits growth of cultured human uveal melanoma cells.
    Hu DN; Roberts JE
    Melanoma Res; 1997 Feb; 7(1):27-31. PubMed ID: 9067962
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression of FGF1 and FGFR1 in human melanoma tissues.
    Xerri L; Battyani Z; Grob JJ; Parc P; Hassoun J; Bonerandi JJ; Birnbaum D
    Melanoma Res; 1996 Jun; 6(3):223-30. PubMed ID: 8819125
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differential gene expression in tumor metastasis: Nm23.
    Freije JM; MacDonald NJ; Steeg PS
    Curr Top Microbiol Immunol; 1996; 213 ( Pt 2)():215-32. PubMed ID: 9053292
    [No Abstract]   [Full Text] [Related]  

  • 10. Active specific immunotherapy of pulmonary metastasis with vaccinia melanoma oncolysate prepared from granulocyte/macrophage-colony-stimulating-factor-gene-encoded vaccinia virus.
    Ju DW; Cao X; Acres B
    J Cancer Res Clin Oncol; 1996; 122(12):716-22. PubMed ID: 8954168
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Overexpression of the cyclin-dependent kinase inhibitor p21(WAF1/CIP1) in human cutaneous malignant melanoma.
    Trotter MJ; Tang L; Tron VA
    J Cutan Pathol; 1997 May; 24(5):265-71. PubMed ID: 9194578
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Melanogenuria as consequence of elevated tyrosinase activity in melanoma.
    Duchon J; Matous B; Pavel S
    Acta Univ Carol Med Monogr; 1977; (78 Pt 2):139-44. PubMed ID: 97931
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Echistatin induces decrease of pp125FAK phosphorylation, disassembly of actin cytoskeleton and focal adhesions, and detachment of fibronectin-adherent melanoma cells.
    Staiano N; Garbi C; Squillacioti C; Esposito S; Di Martino E; Belisario MA; Nitsch L; Di Natale P
    Eur J Cell Biol; 1997 Aug; 73(4):298-305. PubMed ID: 9270872
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Survival of Cloudman mouse melanoma cells after irradiation by solar wavelengths of light.
    Cieszka K; Hill HZ; Xin P; Azure M; Hill GJ; Meyenhofer MF; Boissy RE; Mitchell DL
    Pigment Cell Res; 1997 Aug; 10(4):193-200. PubMed ID: 9263325
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunological gene therapy approaches for malignant melanoma. 1. Tumor-immunological background.
    Bonnekoh B; Bickenbach JR; Roop DR
    Skin Pharmacol; 1997; 10(2):49-62. PubMed ID: 9257373
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Clinical use of interferon].
    Lauta VM
    Clin Ter; 1996; 147(7-8):345-51. PubMed ID: 9118615
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression of the co-stimulatory molecule CD40 on melanoma cells.
    Thomas WD; Smith MJ; Si Z; Hersey P
    Int J Cancer; 1996 Dec; 68(6):795-801. PubMed ID: 8980186
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characterization of antigenic peptides presented by HLA-B44 molecules on tumor cells expressing the gene MAGE-3.
    Fleischhauer K; Fruci D; Van Endert P; Herman J; Tanzarella S; Wallny HJ; Coulie P; Bordignon C; Traversari C
    Int J Cancer; 1996 Nov; 68(5):622-8. PubMed ID: 8938145
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Exploration of interactions between prognostic factors of stage I malignant melanoma.
    Helfenstein U; Schüler G; Bopp M; Morf S; Schüler D
    Melanoma Res; 1996 Aug; 6(4):319-24. PubMed ID: 8873052
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Risk factors associated with etiopathogenesis of non-melanoma skin cancer in Valencia].
    Morales Suarea-Varela MM; Llopis González A; Cejudo Ferragud AI
    An Med Interna; 1996 Apr; 13(4):171-7. PubMed ID: 8688475
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 52.